Forecast & RatingOnly 1 analyst currently covers BioAtla (BCAB.US), with a price target of $500.00 and a rating of "Buy". The sample is very small, so treat this as a reference only. Data as of Apr 6, 2026; this does not constitute investment advice.
Nov 28, 2025
Price forecast
$500.0014937.59%
Forecast & RatingStrong buy
1analysts
Strong buy100.00%
Buy0.00%
Hold0.00%
Sell0.00%
Strong sell0.00%
Strong buy
1
Buy
0
Hold
0
Sell
0
Strong sell
0
Target price forecast
Forecast baselineAug 2, 2026
Forecast met0.0%
Stock price$3.33
Average forecast price$500.0
Highest forecast price$500
Lowest forecast price$500
Average forecast price
$500.0
Highest forecast price
$500
Lowest forecast price
$500
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.